An Oral GLP-1 Receptor Agonist for Adults with Obesity | NEJM
Easy-to-use, oral GLP-1 receptor agonists are of interest as alternatives to injectable formulations approved for weight reduction. An oral nonpeptide GLP-1 receptor agonist shows promise.
New research findings are summarized in this short video.
To see the full article, follow this link: https://nej.md/449Ok27
